Reuters logo
BRIEF-MDxHealth announces ConfirmMDx study provides further validation of epigenetic risk profile
August 10, 2017 / 5:29 AM / 4 months ago

BRIEF-MDxHealth announces ConfirmMDx study provides further validation of epigenetic risk profile

Aug 10 (Reuters) - MDXHEALTH SA:

* REG-CONFIRMMDX STUDY PROVIDES FURTHER VALIDATION OF EPIGENETIC RISK PROFILE

* RESULTS SHOWED THAT TEST CAN PROVIDE TREATING UROLOGISTS WITH DEEPER INSIGHTS INTO A PATIENT‘S RISK FOR AGGRESSIVE PROSTATE CANCER

* RESULTS DEMONSTRATED TEST‘S ABILITY TO HELP IMPROVE IDENTIFICATION OF MEN WITH UNDETECTED AGGRESSIVE DISEASE FROM NEGATIVE BIOPSIES Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below